Loading
PDBj
English日本語简体中文繁體中文한국어
✖
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
PDB: 4 results
276D
DownloadVisualize
BU of 276d by Molmil
SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY
Descriptor: 2'-BROMO-4'-EPIDAUNORUBICIN, DNA (5'-D(*CP*GP*AP*TP*CP*G)-3')
Authors:Gao, Y.-G, Priebe, W, Wang, A.H.-J.
Deposit date:1996-07-22
Release date:1996-09-16
Last modified:2024-02-14
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity.
Eur.J.Biochem., 240, 1996
288D
DownloadVisualize
BU of 288d by Molmil
SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY
Descriptor: 2'-BROMO-4'-EPIDAUNORUBICIN, DNA (5'-D(*CP*GP*TP*AP*CP*G)-3')
Authors:Gao, Y.-G, Priebe, W, Wang, A.H.-J.
Deposit date:1996-07-22
Release date:1996-09-16
Last modified:2024-02-14
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity.
Eur.J.Biochem., 240, 1996
278D
DownloadVisualize
BU of 278d by Molmil
SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY
Descriptor: 2'-BROMO-4'-EPIDAUNORUBICIN, DNA (5'-D(*CP*GP*(G49)P*CP*CP*G)-3'
Authors:Gao, Y.-G, Priebe, W, Wang, A.H.-J.
Deposit date:1996-07-22
Release date:1996-09-16
Last modified:2024-02-14
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity.
Eur.J.Biochem., 240, 1996
277D
DownloadVisualize
BU of 277d by Molmil
SUBSTITUTIONS AT C2' OF DAUNOSAMINE IN THE ANTICANCER DAUNORUBICIN ALTER ITS DNA-BINDING SEQUENCE SPECIFICITY
Descriptor: 2'-BROMO-4'-EPIDAUNORUBICIN, 5'-D(*CP*GP*CP*(G49)P*CP*G)-3'
Authors:Gao, Y.-G, Priebe, W, Wang, A.H.-J.
Deposit date:1996-07-22
Release date:1996-09-16
Last modified:2024-02-14
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity.
Eur.J.Biochem., 240, 1996

223532

PDB entries from 2024-08-07

PDB statisticsPDBj update infoContact PDBjnumon